Unknown OBSERVATIONAL NCT03290014

Sleep Quality in (COPD) Patients (COPD: Chronic Obstructive Pulmonary Disease) (COPD)

Sleep Quality in COPD Patients. A Clinical and Polysomnographic Study

Sponsor: AstraZeneca

Conditions COPD

Interventions Actigraphy Osler test polysomnography

Updated 7 times since 2017 Last updated: Sep 17, 2017 Started: Mar 1, 2017 Primary completion: Jun 30, 2018 Completion: Sep 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on COPD, this trial is ongoing. The trial is conducted by AstraZeneca and has accumulated 7 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Oct 2019 — Jan 2021 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jun 2018 — Oct 2019 [monthly]

Recruiting

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
Oct 2017 — Apr 2018 [monthly]

Recruiting NA

First recorded

Mar 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AstraZeneca
Hospital Universitari Vall d'Hebron Research Institute

Data source: Hospital Universitari Vall d'Hebron Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Barcelona, Spain